Dr. Christopher Matthew Bositis, MD

Dr. Bositis practices at Zuckerberg San Francisco General Hospital and Trauma Center in San Francisco, California, part of City and County of San Francisco, CA.

Dr. Bositis' NPI, 1427054493, was assigned on June 24, 2005. Dr. Bositis graduated from Yale School of Medicine in 1997. Dr. Bositis holds California license C176308.

Dr. Bositis' primary practice is Zuckerberg San Francisco General Hospital and Trauma Center, at 1001 Potrero Avenue, San Francisco, CA 94110 in San Francisco County. The practice phone is (415) 206-8000.

Dr. Bositis' primary practice is Zuckerberg San Francisco General Hospital and Trauma Center in San Francisco, California, part of City and County of San Francisco, CA. The medical group on file is UCSF Department of Radiology & Biomedical Imaging. Dmand AI also links Dr. Bositis to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bositis practices, 3 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Bositis' primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Bositis is board certified in hiv specialist by the American Academy of HIV Medicine. Dmand AI has Dr. Bositis' licenses on file in 4 states: California, Massachusetts, Maryland and Rhode Island.

Dmand AI lists acute stomach ulcer, bipolar disorder, chronic diabetes, chronic hypertension, chronic kidney disease, kidney failure, liver disease and lung disease: COPD, asthma or bronchitis among the conditions Dr. Bositis treats.

CMS data shows 118 Medicare services from Dr. Bositis across 3 procedure codes in 2024, for 68 Medicare patients. Medicare paid $10,627 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 68 Medicare patients who saw Dr. Bositis in 2024. The largest group is 65 to 74, with 34 patients. 75% of them have high blood pressure, and 65% have high cholesterol. Their average risk score is 2.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bositis' median patient age at 67, with 23% women.

In 2024, Dr. Bositis wrote 642 Medicare Part D claims for 94 patients. 78% of them were for generic drugs. CMS names the drug for 224 of them, across 13 drugs with 11 or more claims each, at $145,903 in total drug cost. In 2022, CMS named 327 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Bositis for performance year 2024, reported as part of a group. Dr. Bositis accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 28 papers to Dr. Bositis, published from 2013 to 2025. 2023 was the busiest year, with 3. The most frequent topics are HIV Infections, Zambia and Seizures. Dr. Bositis has published most often in Am J Trop Med Hyg. Dr. Bositis' most frequent co-authors are Gretchen Lano Birbeck, MD, Melissa Anne Elafros, MD, PhD and Jason Okulicz, MD.

Dmand AI links Dr. Bositis to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Acquired Immunodeficiency Syndrome and Slow Virus Diseases.

CMS Open Payments shows 9 general payments to Dr. Bositis from 1 drug or device company in 2019. Consulting fees make up the largest share, 80% of the total. Gilead Sciences, Inc. paid the most, $3,055.

Dr. Bositis graduated from Yale School of Medicine in 1997.

Dr. Bositis is in network with 1 carrier, including CMS Medicare. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.